Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders

Bioorg Med Chem Lett. 2010 Sep 1;20(17):5069-73. doi: 10.1016/j.bmcl.2010.07.029. Epub 2010 Jul 11.

Abstract

A novel imidazobenzazepine template (5a) with potent dual H(1)/5-HT(2A) antagonist activity was identified. Application of a zwitterionic approach to this poorly selective and poorly developable starting point successfully delivered a class of high quality leads, 3-[4-(3-R(1)-2-R-5H-imidazo[1,2-b][2]benzazepin-11-yl)-1-piperazinyl]-2,2-dimethylpropanoic acids (e.g., 9, 19, 20, and 21), characterized by potent and balanced H(1)/5-HT(2A) receptor antagonist activities and good developability profiles.

MeSH terms

  • Humans
  • Receptor, Serotonin, 5-HT1A / drug effects*
  • Receptor, Serotonin, 5-HT2A / drug effects*
  • Serotonin Antagonists / therapeutic use*
  • Sleep Wake Disorders / drug therapy*

Substances

  • Receptor, Serotonin, 5-HT2A
  • Serotonin Antagonists
  • Receptor, Serotonin, 5-HT1A